TAKEDA PHARMACEUTICAL CO LTD 13D/13G Filings for HilleVax, Inc. (HLVX)

TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for HilleVax, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-05-09
06:08 am
Purchase
2022-04-28 13D HilleVax, Inc.
HLVX
TAKEDA PHARMACEUTICAL CO LTD 6,724,000
17.100%
6,724,000increase
(New Position)
Filing